Commentary

Podcast

Pharmacy Focus: Oncology Edition - PARP Inhibitors in Ovarian Cancer

Kirollos Hanna, PharmD, BCPS, BCOP, discussed how PARP inhibitors have changed the treatment landscape of ovarian cancer.

In the second episode of Pharmacy Focus: Oncology Edition, Kirollos Hanna, PharmD, BCPS, BCOP, discussed how PARP inhibitors have changed the treatment landscape of ovarian cancer.

Related Videos
Image Credit: © alenamozhjer - stock.adobe.com
pharmacogenetics testing, adverse drug events, personalized medicine, FDA collaboration, USP partnership, health equity, clinical decision support, laboratory challenges, study design, education, precision medicine, stakeholder perspectives, public comment, Texas Medical Center, DNA double helix
pharmacogenetics challenges, inter-organizational collaboration, dpyd genotype, NCCN guidelines, meta census platform, evidence submission, consensus statements, clinical implementation, pharmacotherapy improvement, collaborative research, pharmacist role, pharmacokinetics focus, clinical topics, genotype-guided therapy, critical thought
Image Credit: © Andrey Popov - stock.adobe.com
Image Credit: © peopleimages.com - stock.adobe.com
TRUST-I and TRUST-II Trials Show Promising Results for Taletrectinib in ROS1+ NSCLC
Image Credit: © Krakenimages.com - stock.adobe.com
Image Credit: © Cavan - stock.adobe.com
Child with cancer -- Image credit: Alexis Scholtz/peopleimages.com | stock.adobe.com
Related Content
Pink ribbon for breast cancer awareness -- Image credit: CozyDigital | stock.adobe.com
October 25th 2024

Ribociclib Recognized by NCCN Clinical Practice Guidelines as Category 1 Preferred Breast Cancer Adjuvant Treatment

Gillian McGovern, Assistant Editor
Pharmacy Focus - Oncology Edition: Advancing Brain Cancer Research and Treatment
September 26th 2024

Pharmacy Focus - Oncology Edition: Advancing Brain Cancer Research and Treatment

Aerobic exercise -- Image credit: Kalim | stock.adobe.com
October 24th 2024

Women Beginning Chemotherapy for Breast Cancer Self-Report Improved Cognitive Function When Participating in Aerobic Exercise

Gillian McGovern, Assistant Editor
Public Health Matters podcast logo
September 19th 2024

Public Health Matters: The Difference Between Misinformation and Disinformation, and How Information Can Inform Evidence-Based Decisions

Multiple myeloma in bone marrow -- Image credit: Saiful52 | stock.adobe.com
October 24th 2024

Advances in CAR T-Cell Therapy and Bispecifics for Relapsed/Refractory Multiple Myeloma

Alana Hippensteele, Managing Editor
Close-up of tumor in lungs -- Image credit: Dr_Microbe | stock.adobe.com
October 23rd 2024

Current Targeted Therapy Options in ROS1-Positive NSCLC

Nicole Bentivegna, PharmD, BCOP